Investors Research Corp’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.13M | Sell |
8,779
-179
| -2% | -$21K | 0.2% | 88 |
|
|
2026
Q1 | $1.08M | Sell |
8,958
-367
| -4% | -$42.4K | 0.21% | 97 |
|
|
2025
Q4 | $982K | Hold |
9,325
| – | – | 0.18% | 109 |
|
|
2025
Q3 | $783K | Buy |
9,325
+120
| +1% | +$9.88K | 0.14% | 142 |
|
|
2025
Q2 | $729K | Hold |
9,205
| – | – | 0.14% | 152 |
|
|
2025
Q1 | $826K | Buy |
9,205
+150
| +2% | +$14K | 0.18% | 126 |
|
|
2024
Q4 | $901K | Sell |
9,055
-121
| -1% | -$12.5K | 0.2% | 114 |
|
|
2024
Q3 | $1.04M | Hold |
9,176
| – | – | 0.23% | 97 |
|
|
2024
Q2 | $1.14M | Hold |
9,176
| – | – | 0.27% | 82 |
|
|
2024
Q1 | $1.21M | Sell |
9,176
-7,307
| -44% | -$901K | 0.28% | 79 |
|
|
2023
Q4 | $1.8M | Hold |
16,483
| – | – | 0.43% | 46 |
|
|
2023
Q3 | $1.7M | Hold |
16,483
| – | – | 0.44% | 44 |
|
|
2023
Q2 | $1.9M | Sell |
16,483
-1,114
| -6% | -$126K | 0.48% | 39 |
|
|
2023
Q1 | $1.87M | Sell |
17,597
-300
| -2% | -$32.4K | 0.49% | 39 |
|
|
2022
Q4 | $1.99M | Sell |
17,897
-175
| -1% | -$17.9K | 0.54% | 36 |
|
|
2022
Q3 | $1.56M | Buy |
18,072
+82
| +0.5% | +$7.32K | 0.48% | 40 |
|
|
2022
Q2 | $1.64M | Buy |
17,990
+46
| +0.3% | +$4.08K | 0.49% | 40 |
|
|
2022
Q1 | $1.47M | Buy |
17,944
+6,668
| +59% | +$526K | 0.42% | 54 |
|
|
2021
Q4 | $864K | Hold |
11,276
| – | – | 0.26% | 101 |
|
|
2021
Q3 | $847K | Hold |
11,276
| – | – | 0.29% | 104 |
|
|
2021
Q2 | $877K | Sell |
11,276
-384
| -3% | -$28.6K | 0.3% | 109 |
|
|
2021
Q1 | $858K | Hold |
11,660
| – | – | 0.32% | 106 |
|
|
2020
Q4 | $910K | Hold |
11,660
| – | – | 0.36% | 79 |
|
|
2020
Q3 | $923K | Hold |
11,660
| – | – | 0.45% | 52 |
|
|
2020
Q2 | $860K | Hold |
11,660
| – | – | 0.43% | 59 |
|
|
2020
Q1 | $856K | Buy |
11,660
+26
| +0.2% | +$2.04K | 0.53% | 28 |
|
|
2019
Q4 | $1.01M | Buy |
11,634
+288
| +3% | +$23.7K | 0.47% | 51 |
|
|
2019
Q3 | $911K | Buy |
11,346
+744
| +7% | +$59.6K | 0.46% | 50 |
|
|
2019
Q2 | $848K | Hold |
10,602
| – | – | 0.44% | 63 |
|
|
2019
Q1 | $841K | Sell |
10,602
-262
| -2% | -$19.6K | 0.45% | 55 |
|
|
2018
Q4 | $792K | Sell |
10,864
-5,423
| -33% | -$383K | 0.55% | 49 |
|
|
2018
Q3 | $1.1M | Buy |
16,287
+488
| +3% | +$31.1K | 0.63% | 29 |
|
|
2018
Q2 | $915K | Buy |
15,799
+1,277
| +9% | +$72K | 0.53% | 47 |
|
|
2018
Q1 | $755K | Sell |
14,522
-210
| -1% | -$11.3K | 0.46% | 64 |
|
|
2017
Q4 | $791K | Buy |
+14,732
| New | +$817K | 0.49% | 56 |
|
Other funds holding MRK
ECSS
Investors Research Corp's MRK Position: Q2 2026 in Review
Investors Research Corp reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $21K and leaving 8,779 shares worth $1.13M. The position accounts for 0.2% of the portfolio, ranked #88.
Investors Research Corp first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.99M in Q4 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Investors Research Corp held 8,779 shares of Merck worth $1.13M as of Q2 2026.
- Investors Research Corp sold 179 Merck shares in Q2 2026, an estimated $21K.
- Merck made up 0.2% of Investors Research Corp's portfolio in Q2 2026, its #88 holding.
- Investors Research Corp first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- Investors Research Corp's Merck position peaked at $1.99M in Q4 2022.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.